79 related articles for article (PubMed ID: 11093782)
1. Impaired resensitization and recycling of the cholecystokinin receptor by co-expression of its second intracellular loop.
Ding XQ; Rao RV; Kuntz SM; Holicky EL; Miller LJ
Mol Pharmacol; 2000 Dec; 58(6):1424-33. PubMed ID: 11093782
[TBL] [Abstract][Full Text] [Related]
2. Roles of cholecystokinin receptor phosphorylation in agonist-stimulated desensitization of pancreatic acinar cells and receptor-bearing Chinese hamster ovary cholecystokinin receptor cells.
Rao RV; Roettger BF; Hadac EM; Miller LJ
Mol Pharmacol; 1997 Feb; 51(2):185-92. PubMed ID: 9203622
[TBL] [Abstract][Full Text] [Related]
3. Dual pathways of internalization of the cholecystokinin receptor.
Roettger BF; Rentsch RU; Pinon D; Holicky E; Hadac E; Larkin JM; Miller LJ
J Cell Biol; 1995 Mar; 128(6):1029-41. PubMed ID: 7896869
[TBL] [Abstract][Full Text] [Related]
4. Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking.
Go WY; Holicky EL; Hadac EM; Rao RV; Miller LJ
Am J Physiol; 1998 Jul; 275(1):G56-62. PubMed ID: 9655684
[TBL] [Abstract][Full Text] [Related]
5. Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.
Cawston EE; Harikumar KG; Miller LJ
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C615-27. PubMed ID: 22049215
[TBL] [Abstract][Full Text] [Related]
6. CCK receptor phosphorylation exposes regulatory domains affecting phosphorylation and receptor trafficking.
Rao RV; Holicky EL; Kuntz SM; Miller LJ
Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1986-92. PubMed ID: 11078715
[TBL] [Abstract][Full Text] [Related]
7. Cellular handling of unoccupied and agonist-stimulated cholecystokinin receptor determined by immunolocalization.
Fischer de Toledo C; Roettger BF; Morys-Wortmann C; Schmidt WE; Miller LJ
Am J Physiol; 1997 Mar; 272(3 Pt 1):G488-97. PubMed ID: 9124569
[TBL] [Abstract][Full Text] [Related]
8. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell.
Roettger BF; Rentsch RU; Hadac EM; Hellen EH; Burghardt TP; Miller LJ
J Cell Biol; 1995 Aug; 130(3):579-90. PubMed ID: 7622559
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors.
Ozcelebi F; Rao RV; Holicky E; Madden BJ; McCormick DJ; Miller LJ
J Biol Chem; 1996 Feb; 271(7):3750-5. PubMed ID: 8631990
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization.
Trincavelli ML; Tuscano D; Cecchetti P; Falleni A; Benzi L; Klotz KN; Gremigni V; Cattabeni F; Lucacchini A; Martini C
J Neurochem; 2000 Oct; 75(4):1493-501. PubMed ID: 10987829
[TBL] [Abstract][Full Text] [Related]
11. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor.
Harikumar KG; Puri V; Singh RD; Hanada K; Pagano RE; Miller LJ
J Biol Chem; 2005 Jan; 280(3):2176-85. PubMed ID: 15537636
[TBL] [Abstract][Full Text] [Related]
13. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.
Roettger BF; Pinon DI; Burghardt TP; Miller LJ
Am J Physiol; 1999 Mar; 276(3):C539-47. PubMed ID: 10069980
[TBL] [Abstract][Full Text] [Related]
14. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
[TBL] [Abstract][Full Text] [Related]
15. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
Ghanekar D; Hadac EM; Holicky EL; Miller LJ
J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
[TBL] [Abstract][Full Text] [Related]
16. Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis.
Dong M; Ding XQ; Pinon DI; Hadac EM; Oda RP; Landers JP; Miller LJ
J Biol Chem; 1999 Feb; 274(8):4778-85. PubMed ID: 9988716
[TBL] [Abstract][Full Text] [Related]
17. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A.
Tarasova NI; Stauber RH; Choi JK; Hudson EA; Czerwinski G; Miller JL; Pavlakis GN; Michejda CJ; Wank SA
J Biol Chem; 1997 Jun; 272(23):14817-24. PubMed ID: 9169450
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-induced desensitization, receptor phosphorylation, and internalization in the CHP212 neuroblastoma cell line.
Rao RV; Hadac EM; Roettger BF; Miller LJ
J Neurochem; 1997 Jun; 68(6):2356-62. PubMed ID: 9166728
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
Garland AM; Grady EF; Lovett M; Vigna SR; Frucht MM; Krause JE; Bunnett NW
Mol Pharmacol; 1996 Mar; 49(3):438-46. PubMed ID: 8643083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
